Drugdiscovery >> Clinical Trials >> News
5906
Views
title
Boehringer Ingelheim’s COPD drug successful in Phase 3 studies - drugdiscovery.com


The results show that olodaterol Respimat, in addition to usual care, provides statistically significant improvements in lung function in patients with COPD, compared to usual care alone.
Read More >>


Tags: olodaterol Respimat, COPD, drug, new treatment, Boehringer Ingelheim, Boehringer, clinical trial - September 12, 2013
Related Articles
3927
Views
'Double Chin' drug successful in two late-stage clinical studies 'Double Chin' drug successful in two late-stage clinical studies
Kythera Biopharmaceuticals’ drug, ATX-101, which is used for reducing fat in the submental area of the neck, reached its main and secondary goals in late stage clinical trials. Read More >>

Tags: Kythera, double chin, new drug, clinical trials, ATX-101

8104
Views
Medivir’s bone drug successful in Phase 1 clinical trial Medivir’s bone drug successful in Phase 1 clinical trial
The investigational cathepsin K inhibitor MIV-711, used as the treatment of osteoarthritis and other bone related disorders, has shown to be safe and tolerable at doses where it potently decreased car Read More >>

Tags: Medivir, cathepsin K inhibitor, MIV-711, osteoarthritis, bone, drug, invstigational, clinical trial

4685
Views
Theravance’s experimental COPD drug meets study goal Theravance’s experimental COPD drug meets study goal
Theravance announced that the drug, named TD-408, taken as a once-per-day treatment for moderate to severe chronic obstructive pulmonary disease met its goals in a midstage clinical trial. Read More >>

Tags: Theravance, experimental drug, COPD, lung disease, clinical trial

20068
Views
Lilly’s experimental lung cancer drug successful in phase III clinical trial Lilly’s experimental lung cancer drug successful in phase III clinical trial
Eli Lilly & Co. announced in a press release that necitumumab (IMC-11F8), in combination with gemcitabine and cisplatin, as first-line treatment for stage IV squamous cell non-small cell lung cancer Read More >>

Tags: Eli Lilly, necitumumab, advanced lung cancer, new drug,experimental drug, stage IV, squamous cell non-small cell lung cancer

7668
Views
Mallinckrodt's pain drug successful in Phase 3 clinical trial Mallinckrodt's pain drug successful in Phase 3 clinical trial
The experimental pain drug MNK-795 met the primary endpoint of a Phase 3 study, improving the pain scores, compared to placebo, in patients with acute pain after surgery. Read More >>

Tags: pain drug, MNK-795, clinical trial, Mallinckrodt

7845
Views
Glioblastoma multiforme vaccine successful in Phase 2 Glioblastoma multiforme vaccine successful in Phase 2
Agenus’ Prophage Series G-100 (HSPPC-96), used in combination with the current standard of care in patients with newly diagnosed glioblastoma multiforme, showed significant improvement in progressio Read More >>

Tags: glioblastoma multiiforme, GBM, vaccine, clinical trial, Ageon, HSPPC-96,progression free survival

7231
Views
Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial Novo Nordisk’s type 2 diabetes therapy successful in Phase 3 trial
The data from DUALT 1 trial show that an investigational therapy IDegLira [Tresiba (insulin degludec)/Victoza (liraglutide injection)] achieved statistically significant greater reduction in blood sug Read More >>

Tags: Novo Nordisk, type 2 diabetes, DUALT 1 trial, IDegLira, Tresiba, insulin degludec, Victoza, liraglutide, combination

6045
Views
Trajenta successful  in Phase III trial in elderly Type 2 diabetes patients Trajenta successful in Phase III trial in elderly Type 2 diabetes patients
Trajenta (linagliptin), marketed by Eli Lilly and Boehringer Ingelheim, showed safe and effective in Phase III trial, significantly reducing the blood glucose levels in elderly people with Type 2 diab Read More >>

Tags: Trajenta, type 2 diabetes, elderly, blood glucose control

13253
Views
PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma PAT-SM6 antibody successful in Phase I/IIa clinical trial for multiple myeloma
Patrys Limited has released additional clinical data for six end-stage, multi-resistant multiple myeloma patients treated with PAT-SM6. The trial is progressing to its 4th and final patient cohort. Read More >>

Tags: multiple myeloma, clinical trial, PAT-SM6, antibody, Patrys Limited, end stage

5600
Views
Afrezza inhaled insulin successful in Phase III trials Afrezza inhaled insulin successful in Phase III trials
MannKind’s inhaled insulin Afrezza showed clearly positive results in Phase III studies on Type 1 and Type 2 diabetes. The new drug application will be submitted to the FDA early in the fourth qua Read More >>

Tags: MannKind, inhaled insulin, Afrezza, clinical trials,type 1, type 2, diabetes

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013